Quantitative immunofluorescence and immunoelectron microscopy of the topoisomerase IIα associated with nuclear matrices from wild-type and drug- resistant Chinese hamster ovary cell lines

Journal of Cellular Biochemistry

Volumn 67, Issue 1, 1997, Pages 112-130

  Valkov, Nikola I ^a   Gump, Jana L ^a   Sullivan, Daniel M ^a,b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b NONE   (United States)

Author keywords

Decatenation; DNase II; In situ nuclear matrix; Mitotic chromosomes; RNP; VP 16

Indexed keywords

AMSACRINE; ANTINEOPLASTIC AGENT; DEOXYRIBONUCLEASE II; DNA TOPOISOMERASE (ATP HYDROLYSING); DOXORUBICIN; ETOPOSIDE; MITOXANTRONE; TOPOISOMERASE 2ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY SPECIFICITY; ARTICLE; CELL LABELING; CELLULAR DISTRIBUTION; CHO CELL; DNA DETERMINATION; DNA STRUCTURE; DRUG RESISTANCE; ENZYME ANALYSIS; IMMUNOELECTRON MICROSCOPY; IMMUNOFLUORESCENCE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS;

ANIMALS; ANTIGENS, NEOPLASM; BLOTTING, WESTERN; CHO CELLS; CRICETINAE; CYTOPLASM; DEOXYRIBONUCLEASE I; DNA TOPOISOMERASES, TYPE II; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; DRUG RESISTANCE; ENDODEOXYRIBONUCLEASES; ENZYME INHIBITORS; ETOPOSIDE; ISOENZYMES; MICROSCOPY, FLUORESCENCE; MICROSCOPY, IMMUNOELECTRON; NUCLEAR MATRIX;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS;

EID: 0030967776     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19971001)67:1<112::AID-JCB12>3.0.CO;2-J     Document Type: Article

References (64)

1. Andreassen PR, Lacroix FB, Margolis RL (1997): Chromosomes with two intact axial cores are induced by 62 checkpoint override: Evidence that DNA decatenation is not required to template the chromosome structure. J Cell Biol 136:29-43.
2. Berrios M, Osheroff N, Fisher PA (1985): In situ localization of DNA topoisomerase II, a major polypeptide component of the Drosophila nuclear matrix fraction. Proc Natl Acad Sci U S A 82:4142-4146.
3. Birrell GB, Hedberg KK, Griffith OH (1987): Pitfalls of immunogold labeling: Analysis by light microscopy, transmission electron microscopy, and photoelectron microscopy. J Histochem Cytochem 35:843-853.
4. Burden DA, Goldsmith LJ, Sullivan DM (1993): Cell-cycle-dependent phosphorylation and activity of Chinese-hamster ovary topoisomerase II. Biochem J 293:297-304.
5. Chew EC, Yang L, Cheng-Chew SB, Leung PY, Jiao RJ, Zhai ZH (1993): Microwave fixation of nuclear matrix in tumor cells. Anticancer Res 13:2277-2280.
6. Cook PR (1988): The nucleoskeleton: Artefact, passive framework or active site? J Cell Sci 90:1-6.
7. Danks MK, Qui J, Catapano CV, Schmidt CA, Beck WT, Fernandes DJ (1994): Subcellular distribution of the a and β topoisomerase II-DNA complexes stabilized by VM-26. Biochem Pharmacol 48:1785-1795.
8. de Graaf A, van Bergen en Henegouven PMP, Meijne AML, van Driel R, Verkleij AJ (1991): Ultrastructural localization of nuclear matrix proteins in HeLa cells using silver-enhanced ultra-small gold probes. J Histochem Cytochem 39:1035-1045.
9. Drake FH, Zimmerman JP, McCabe FL, Bartus HF, Per SR, Sullivan DM, Ross WE, Mattern MR, Johnson RK, Crooke ST, Mirabelli CK (1987): Purification of topoisomerase II from amsacrine-resistant P388 leukemia cells: Evidence for two forms of the enzyme. J Biol Chem 262:16739-16747.
10. Duplantier B, Jannink G, Sikorav J-L (1995): Anaphase chromatid motion: Involvement of type II DNA topoisomerases. Biophys J 69:1596-1605.
11. Earnshaw WC, Halligan B, Cooke CA, Heck MMS, Liu LF (1985): Topoisomerase II is a structural component of mitotic chromosome scaffolds. J Cell Biol 100:1706-1715.
12. Feldhoff PW, Mirski SEL, Cole SPC, Sullivan DM (1994): Altered subcellular distribution of topoisomerase IIα in a drug-resistant human small cell lung cancer cell line. Cancer Res 54:756-762.
13. Fernandes DJ, Catapano CV (1991): Nuclear matrix targets for anticancer agents. Cancer Cells 3:134-140.
14. Fernandes DJ, Catapano CV (1995): The nuclear matrix as a site of anticancer drug action. Int Rev Cytol 162A:539-577.
15. Fernandes DJ, Smith-Nanni C, Paff MT, Neff T-AM (1988): Effects of antileukemia agents on nuclear matrix-bound DNA replication in CCRF-CEM leukemia cells. Cancer Res 48:1850-1855.
16. Fernandes DJ, Danks MK, Beck WT (1990): Decreased nuclear matrix DNA topoisomerase II in human leukemia cells resistant to VM-26 and m-AMSA. Biochemistry 29:4235-4241.
17. Fey EG, Krochmalnic G, Penman S (1986): The non-chromatin substructures of the nucleus: The ribonucleoprotein (RNP)-containing and RNP-depleted matrices analyzed by sequential fractionation and resinless section electron microscopy. J Cell Biol 102:1654-1665.
18. Fischer D, Hock R, Scheer U (1993): DNA topoisomerase II is not detectable on lampbrush chromosomes but enriched in the amplified nucleoli of Xenopus oocytes. Exp Cell Res 209:255-260.
19. Fisher PA (1989): Chromosomes and chromatin structure: The extrachromosomal karyoskeleton. Curr Opin Cell Biol 1:447-453.
20. Fisher PA, Lin L, McConnell M, Greenleaf A, Lee J-M, Smith DE (1989): Heat shock-induced appearance of RNA polymerase II in karyoskeletal protein-enriched (nuclear "matrix") fractions correlates with transcriptional shutdown in Drosophila melanogaster. J Biol Chem 264:3464-3469.
21. Harker WG, Slade DL, Parr RL, Feldhoff PW, Sullivan DM, Holguin MH (1995): Alterations in the topoisomerase IIα gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomerase IIβ enzyme in a mitoxantrone-resistant HL-60 human leukemia cell line. Cancer Res 55:1707-1716.
22. He D, Nickerson JA, Penman S (1990): Core filaments of the nuclear matrix. J Cell Biol 110:569-580.
23. He DC, Martin T, Penman S (1991): Localization of heterogeneous nuclear ribonucleoprotein in the interphase nuclear matrix core filaments and on perichromosomal filaments at mitosis. Proc Natl Acad Sci U S A 88:7469-7473.
24. Heck MMS, Earnshaw WC (1986): Topoisomerase II: A specific marker for cell proliferation. J Cell Biol 103:2569-2581.
25. Hempel K, Strätling WH (1996): The chicken lysozyme gene 5′ MAR and the Drosophila histone SAR are electroelutahle from encapsulated and digested nuclei. J Cell Sci 109:1459-1469.
26. Hirano T, Mitchison TJ (1993): Topoisomerase II does not play a scaffolding role in the organization of mitotic chromosomes assembled in Xenopus egg extracts. J Cell Biol 120:601-612.
27. Hsiang Y, Wu H-Y, Liu LF (1988): Proliferation-dependent regulation of DNA topoisomerase II in cultured human cells. Cancer Res 48:3230-3235.
28. Jack RS, Eggert H (1992): The elusive nuclear matrix. Eur J Biochem 209:503-509.
29. Jackson DA (1991): Structure-function relationships in eukaryotic nuclei. Bioessays 13:1-10.
30. Jackson DA, Cook PR (1988): Visualization of a filamentous nucleoskeleton with a 23 nm axial repeat. EMBO J 7: 3667-3677.
31. Kaufmann SH, Shaper JH (1991): Association of topoisomerase II with the hepatoma cell nuclear matrix: The role of intermolecular disulfide bond formation. Exp Cell Res 192:511-523.
32. Krachmarov CP, Traub P (1993): Heat-induced morphological and biochemical changes in the nuclear lamina from Ehrlich ascites tumor cells in vivo. J Cell Biochem 52:308-319.
33. Krachmarov CP, Tasheva B, Markov D, Hancock R, Dessev G (1986): Isolation and characterization of nuclear lamina from Ehrlich ascites tumor cells. J Cell Biochem 30:351-359.
34. Labhart P, Koller T, Wunderli H (1982): Involvement of higher order chromatin structures in metaphase chromosome organization. Cell 30:115-121.
35. Lewis CD, Laemmli UK (1982): Higher order metaphase chromosome structure: Evidence for metalloprotein interactions. Cell 17:849-858.
36. Mattern KA, Humbel BM, Muijsers AO, de Jong L, van Driel R (1996): hnRNP proteins and B23 are the major proteins of the internal nuclear matrix of HeLa S3 cells. J Cell Biochem 62:275-289.
37. McConnell M, Whalen AM, Smith DE, Fisher PA (1987): Heat shock-induced changes in the structural stability of proteinaceous karyoskeletal in vitro and morphological effects in situ. J Cell Biol 105:1087-1098.
38. Meller VH, Fisher PA (1995): Nuclear distribution of Drosophila topoisomerase II is sensitive to both RNase and DNase. J Cell Sci 108:1651-1657.
39. Meller VH, McConnell M, Fisher PA (1994): An RNase-sensitive particle containing Drosophila melanogaster DNA topoisomerase II. J Cell Biol 126:1331-1340.
40. Meyer KN, Kjeldsen E, Straub T, Knudsen BR, Hickson ID, Kikuchi A, Kreipe H, Boege P (1997): Cell cycle-coupled relocation of types I and II topoisomerases and modulation of catalytic enzyme activities. J Cell Biol 136:775-788.
41. Miller OL, Bakken AH (1972): Morphological studies on transcription. Acta Endocrinol 168 (Suppl):155-173.
42. Mirski SEL, Cole SPC (1995): Cytoplasmic localization of a mutant M, 160,000 topoisomerase IIα is associated with the loss of putative bipartite nuclear localization signals in a drug-resistant human lung cancer cell line. Cancer Res 55:2129-2134.
43. Nickerson JA, Krockmalnic G, Wan KM, Penman S (1997): The nuclear matrix revealed by eluting chromatin from a cross-linked nucleus. Proc Natl Acad Sci U S A 94:4446-4450.
44. Paulson JR (1989): Scaffold morphology in histone-depleted HeLa metaphase chromosomes. Chromosoma 97:289-295.
45. Penman S (1995): Rethinking cell structure. Proc Natl Acad Sci U S A 92:5251-5257.
46. Petrov P, Drake FH, Loranger A, Huang W, Hancock R (1993): Localization of DNA topoisomerase II in Chinese hamster fibroblasts by confocal and electron microscopy. Exp Cell Res 204:73-81.
47. Pienta KJ, Lehr JE (1993): Inhibition of prostate cancer growth by estramustine and etoposide: Evidence for interaction at the nuclear matrix. J Urol. 149:1622-1625.
48. Pienta KJ, Partin AW, Coffey DS (1989): Cancer as a disease of DNA organization and dynamic cell structure. Cancer Res 49:2525-2532.
49. Poljak E, Kas E (1995): Resolving the role of topoisomerase II in chromatin structure and function. Trends Cell Biol 5:348-354.
50. Qiu J, Catapano CV, Fernandes DJ (1996): Formation of topoisomerase IIα complexes with nascent DNA is related to VM-26-induced cytotoxicity. Biochemistry 35: 16354-16360.
51. Roberge M, Dahmus ME, Bradbury EM (1988): Chromosomal loop/nuclear matrix organization of transcriptionally active and inactive RNApolymerases in HeLa nuclei. J Mol Biol 201:545-555.
52. Safiejko-Mroczka B, Bell PB Jr (1996): Bifunctional protein cross-linking reagents improve labeling of cytoskeletal proteins for qualitative and quantitative fluorescence microscopy. J Histochem Cytochem 44:641-656.
53. Schröder HC, Trölltsch D, Friese U, Bachmann M, Müller WEG (1987): Mature mRNA is selectively released from the nuclear matrix by an ATP/dATP-dependent mechanism sensitive to topoisomerase inhibitors. J Biol Chem 262:8917-8925.
54. Smalheiser NR (1996): Proteins in unexpected locations. Mol Biol Cell 7:1003-1014.
55. Sullivan DM, Latham MD, Ross WE (1987): Proliferation-dependent topoisomerase II content as a determinant of antineoplastic drug action in human, mouse, and Chinese hamster ovary cells. Cancer Res 47:3973-3979.
56. Sullivan DM, Latham MD, Rowe TC, Ross WE (1989): Purification and characterization of an altered topoisomerase II from a drug-resistant Chinese hamster ovary cell line. Biochemistry 28:5680-5687.
57. Sullivan DM, Eskildsen LA, Groom KR, Webb CD, Latham MD, Martin AW, Wellhausen SR, Kroeger PE, Rowe TC (1993): Topoisomerase II activity involved in cleaving DNA into topological domains is altered in a multiple drug-resistant Chinese hamster ovary cell line. Mol Pharmacol 43:207-216.
58. Sumner AT (1996): The distribution of topoisomerase II on mammalian chromosomes. Chromosome Res 4:5-14.
59. Swedlow JR, Sedat JW, Agard DA (1993): Multiple chromosomal populations of topoisomerase II detected in vivo by time-lapse, three-dimensional wide-field microscopy. Cell 73:97-108.
60. Taagepera S, Rao PN, Drake FH, Gorbsky GJ (1993): DNA topoisomerase IIα is the major chromosome protein recognized by the mitotic phosphoprotein antibody MPM-2. Proc Natl Acad Sci U S A 90:8407-8411.
61. Uemura T, Ohkura H, Adachi Y, Morino K, Shiozaki K, Yanagida M (1987): DNA topoisomerase II is required for condensation and separation of mitotic chromosomes in S. pombe. Cell 50:917-925.
62. Wang X, Traub P (1991): Resinless section immunogold electron microscopy of karyo-cytoskeletal frameworks of eukaryotic cells cultured in vitro: Absence of a salt-stable nuclear matrix from mouse plasmacytoma MPC-11 cells. J Cell Sci 98:107-122.
63. Webb CD, Latham MD, Lock RB, Sullivan DM (1991): Attenuated topoisomerase II content directly correlates with a low level of drug resistance in a Chinese hamster ovary cell line. Cancer Res 51:6543-6549.
64. Wolverton JS, Danks MK, Granzen B, Beck WT (1992): DNA topoisomerase II immunostaining in human leukemia and rhabdomyosarcoma cell lines and their responses to topoisomerase II inhibitors. Cancer Res 52: 4248-4253.